Among its recommendations, the association said Congress should work to strengthen shortage disclosure requirements for drugmakers, incentivize manufacturers to make contingency plans in case of a shortage and assess drug shortages as a national security threat.
The FDA should work to establish a manufacturing quality rating system, improve its drug shortages list, develop a list of critical drugs and disclose more information on the quality of outsourcing facilities that compound drugs during a shortage, it said.
Read the full news release here.
More articles on pharmacy:
Hospital-owned drug company attracts 12 more health systems
How nurses are becoming integral to pharma marketing: 7 notes
4 tips for managing drug spend from Alameda Health System’s Dr. Yi-Chih Peng
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.